← Evidence map

ArticleBlood neoplasia2026

Increased duration of time without transfusion reliance with imetelstat vs placebo in the phase 3 IMerge trial.

Mikkael A Sekeres et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42027748